First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
20 hedge funds and large institutions have $6.79M invested in First Trust Nasdaq Pharmaceuticals ETF in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.35M | |
| 2 | +$433K | |
| 3 | +$219K | |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$73.1K |
| 5 |
VCM
Vivaldi Capital Management
Chicago,
Illinois
|
+$67.2K |
Top Sellers
| 1 | -$1.28M | |
| 2 | -$133K | |
| 3 | -$19.2K | |
| 4 |
CA
Continuum Advisory
Eagle,
Idaho
|
-$17.5K |
| 5 |
WFA
WMG Financial Advisors
Knoxville,
Tennessee
|
-$10.9K |
